1
00:00:00,090 --> 00:00:02,730
Welcome, everyone to Becker's
Healthcare podcast series.

2
00:00:03,310 --> 00:00:05,210
I'm Ryan Mohamed with Becker's Healthcare.

3
00:00:05,590 --> 00:00:08,090
I'm thrilled to have
with me today Dr. Avni,

4
00:00:08,390 --> 00:00:12,610
the core cardiologist and president of
Catholic Health Physician Partners. Dr.

5
00:00:12,670 --> 00:00:14,250
So nice to talk with
you today. How are you?

6
00:00:15,210 --> 00:00:16,190
I'm wonderful. How are you?

7
00:00:16,660 --> 00:00:18,950
Good, thank you so much.
Uh, well, to begin,

8
00:00:19,080 --> 00:00:22,470
would you mind introducing yourself and
telling us a bit about your background?

9
00:00:23,410 --> 00:00:27,460
Sure. Uh, again, Dr. Abni
Theor. Um, I am a cardiologist,

10
00:00:27,460 --> 00:00:31,740
general cardiologist by background,
um, trained, uh, mostly in Boston,

11
00:00:31,880 --> 00:00:34,700
at Harvard Medical School, mass
General and, and Boston Medical Center.

12
00:00:35,200 --> 00:00:39,300
And have been practicing now as a
clinical cardiologist in the New York, uh,

13
00:00:39,300 --> 00:00:43,820
long Island area for about 15 years.
Um, from an administrative side,

14
00:00:43,900 --> 00:00:48,380
I started my career, um, relatively
early. Um, in, in leadership.

15
00:00:48,620 --> 00:00:50,780
I initially, um, was, uh,

16
00:00:51,100 --> 00:00:54,300
a leader in cardiology and
my medical group and, uh,

17
00:00:54,300 --> 00:00:56,780
helped develop and build out
many cardiology practices.

18
00:00:57,120 --> 00:00:59,100
And in time I transitioned, uh,

19
00:00:59,100 --> 00:01:02,140
into overseeing other
specialties in primary care. Um,

20
00:01:02,170 --> 00:01:04,300
I've now been with Catholic Health, uh,

21
00:01:04,300 --> 00:01:08,860
here in Long Island in New York for about
five years, a little over five years.

22
00:01:09,000 --> 00:01:09,460
And, uh,

23
00:01:09,460 --> 00:01:12,620
currently in the physician as president
of Catholic Health Physician Partners

24
00:01:12,620 --> 00:01:16,900
Medical Group. And this is our employed
physician group, um, across, uh, Queens,

25
00:01:16,960 --> 00:01:21,740
Nassau on Long Island. I'm also a mom.
I have two kids, uh, both grown up now,

26
00:01:22,000 --> 00:01:25,580
um, and, uh, you know, have,
uh, a native Long Island.

27
00:01:25,800 --> 00:01:27,900
So I'm really happy to
be, uh, working out here,

28
00:01:28,000 --> 00:01:31,740
taking care of PA patients and helping
healthcare improve in, in my hometown.

29
00:01:33,630 --> 00:01:35,960
Yeah, absolutely. Thank you
so much for that background.

30
00:01:36,220 --> 00:01:39,640
And to begin with the real
questions of the podcast, um,

31
00:01:39,640 --> 00:01:44,120
the first thing I wanted to ask you is
what are the top three biggest issues in

32
00:01:44,120 --> 00:01:45,040
cardiology today?

33
00:01:46,660 --> 00:01:48,960
So I think, um, three key issues, um,

34
00:01:49,180 --> 00:01:54,000
or sort of challenges and opportunities
facing the, the cardiology space today.

35
00:01:54,140 --> 00:01:56,920
Um, number one I think
is, is really just, uh,

36
00:01:56,920 --> 00:01:59,360
the impact of cardiovascular
disease in our society.

37
00:01:59,830 --> 00:02:03,440
It's the top cause of death in the
United States. Um, still today,

38
00:02:03,760 --> 00:02:07,080
although there's a lot of programs,
treatments, uh, and awareness around this,

39
00:02:07,080 --> 00:02:09,480
it still remains the
leading cause of death. Um,

40
00:02:09,480 --> 00:02:12,400
and if we look back since
the 1950s when we had, uh,

41
00:02:12,560 --> 00:02:16,440
the beginning of major advances in, in
cardiac, uh, treatment and diagnosis,

42
00:02:16,980 --> 00:02:21,040
you know, initially we saw significant
declines in cardiovascular mortality,

43
00:02:21,380 --> 00:02:23,720
but in the last few years,
um, despite, you know,

44
00:02:23,720 --> 00:02:25,680
continued research advancement, um,

45
00:02:25,680 --> 00:02:29,520
and resources being poured into
cardiovascular disease improvement, um,

46
00:02:29,520 --> 00:02:33,000
we have seen some plateauing in
the improvement in mortality.

47
00:02:33,420 --> 00:02:36,880
So I think that's an interesting and
an important, uh, finding or trend.

48
00:02:37,460 --> 00:02:40,960
And I think, uh, one of the opportunities
or challenges for us here, uh,

49
00:02:40,960 --> 00:02:42,640
both in the United States and globally,

50
00:02:42,980 --> 00:02:47,080
is perhaps looking at the areas we focus
on in terms of diagnosing and managing

51
00:02:47,080 --> 00:02:49,800
cardiac illness, um, and perhaps, uh,

52
00:02:49,800 --> 00:02:52,880
switching some of our focus
towards prevention. Um,

53
00:02:52,940 --> 00:02:55,360
and also towards specific
therapies, whether there's, uh,

54
00:02:55,360 --> 00:02:59,440
drugs or other types of treatments that
have really strongly proven mortality

55
00:02:59,540 --> 00:03:03,480
impact. Um, so I think there
will be some shift in focus, um,

56
00:03:03,580 --> 00:03:08,080
to make sure that we continue to
see a decline, not a plateau or, uh,

57
00:03:08,080 --> 00:03:12,960
worse in, in the cardiovascular mortality
rates. So that's one key area, um,

58
00:03:12,980 --> 00:03:17,320
in my opinion, and I think perhaps one
of the most important ones. Um, secondly,

59
00:03:18,000 --> 00:03:20,760
I think we all know this and we're
always reading and hearing about this,

60
00:03:20,760 --> 00:03:23,920
the cost of healthcare is rising
in the United States and, uh,

61
00:03:23,920 --> 00:03:28,640
cardiac management, cardiac disease,
you know, contributes in the top 5%,

62
00:03:28,820 --> 00:03:32,600
um, for cost and especially
with our aging population,

63
00:03:32,600 --> 00:03:34,920
cardiovascular disease as
a significant focus area.

64
00:03:34,920 --> 00:03:39,120
So I think we do have to look at, um,
again, how we can bend that cost curve,

65
00:03:39,260 --> 00:03:41,120
um, specifically in, in cardiology.

66
00:03:42,860 --> 00:03:47,280
And I guess the third area is, um,
uh, access to care and, you know,

67
00:03:47,280 --> 00:03:50,240
especially through the pandemic.
Um, and otherwise since, you know,

68
00:03:50,240 --> 00:03:53,840
we've really been focused in healthcare
in general on improving access to care

69
00:03:53,900 --> 00:03:58,680
in particular, um, in the communities
where we see there are, you know,

70
00:03:58,680 --> 00:04:02,800
barriers to access where there are
socioeconomic and other disparities. Um,

71
00:04:02,800 --> 00:04:05,800
again, cardiovascular disease is
prevalent in these communities,

72
00:04:06,300 --> 00:04:08,640
and I think making sure that
all of our patients are,

73
00:04:09,100 --> 00:04:13,920
are provided equal access to care, uh,
we enhance, um, prevention strategies,

74
00:04:13,920 --> 00:04:15,320
we enhance early diagnosis,

75
00:04:15,780 --> 00:04:18,680
and we make sure that people have access
to the right treatments and the right

76
00:04:19,050 --> 00:04:22,000
engagement with their physicians
and other clinical care team is,

77
00:04:22,000 --> 00:04:24,920
is critically important in
cardiology. So I think, you know,

78
00:04:24,970 --> 00:04:29,000
those are my three areas really I think
for us to focus on in the coming, uh,

79
00:04:29,000 --> 00:04:30,920
year or two really is spending that, um,

80
00:04:31,070 --> 00:04:35,600
cost curve access to care and
focusing on how we can, um,

81
00:04:35,970 --> 00:04:39,480
shift our clinical focus
and our therapeutic focus
to making sure we're seeing

82
00:04:39,480 --> 00:04:41,480
some improvement in
cardiovascular mortality rates.

83
00:04:43,210 --> 00:04:46,300
Yeah, absolutely. And, uh,
talking about the future,

84
00:04:46,400 --> 00:04:51,060
the next thing I wanted to ask you is
how do you see heart care evolving over

85
00:04:51,300 --> 00:04:53,060
the next 18 months or so?

86
00:04:54,530 --> 00:04:55,580
Well, you know, it's interesting.

87
00:04:55,660 --> 00:04:59,540
I think all of healthcare has seen like
a real rise in in digital health and,

88
00:04:59,560 --> 00:05:03,220
and artificial intelligence.
I think across the board, um,

89
00:05:03,240 --> 00:05:06,220
as a cardiologist and somebody who's
always interested in what's coming down,

90
00:05:06,440 --> 00:05:10,620
uh, the pike, if you will, in cardiology,
there's been significant strides, um,

91
00:05:10,850 --> 00:05:12,980
made in digital health and ai, uh,

92
00:05:12,980 --> 00:05:16,460
both in terms of supporting our clinical
decision making as physicians and care

93
00:05:16,460 --> 00:05:20,140
teams, uh, helping us, uh, treat
patients and giving us, uh,

94
00:05:20,370 --> 00:05:24,540
good tech support as well as good data
support in making clinical decisions.

95
00:05:24,660 --> 00:05:28,500
I think, uh, some of the technological
advances as well as some of the, um,

96
00:05:28,500 --> 00:05:30,500
information that's driven to us, um,

97
00:05:30,890 --> 00:05:34,860
through artificial intelligence and
predictive modeling is very, very helpful.

98
00:05:35,440 --> 00:05:39,220
Um, additionally I think for patients,
digital health has become a big player,

99
00:05:39,350 --> 00:05:41,380
which it really wasn't,
um, some years ago.

100
00:05:41,800 --> 00:05:45,500
And patients really navigating their
own healthcare with digital tools, um,

101
00:05:45,560 --> 00:05:47,140
has become very prevalent now.

102
00:05:47,200 --> 00:05:51,380
And we see that a lot in our cardiac
patient population because they really are

103
00:05:51,380 --> 00:05:54,980
monitoring their own vital signs, their
own blood pressures, their weights, um,

104
00:05:54,980 --> 00:05:57,600
other metrics and parameters through, um,

105
00:05:57,680 --> 00:06:01,080
wearable or other kind of
easily portable digital devices.

106
00:06:01,380 --> 00:06:03,640
So I think in the next year
and a half or so, you know,

107
00:06:03,820 --> 00:06:07,480
AI and digital platforms and digital
health in general I think are gonna really

108
00:06:07,480 --> 00:06:11,280
impact how we practice cardiology both
as providers and how cardiac patients

109
00:06:11,280 --> 00:06:12,113
take care of themselves.

110
00:06:14,100 --> 00:06:14,590
Yes,

111
00:06:14,590 --> 00:06:19,480
I've definitely heard that repeatedly
over the last couple months about ai

112
00:06:20,140 --> 00:06:22,720
and that can definitely
be an exciting thing. Um,

113
00:06:22,720 --> 00:06:24,760
the next thing I wanted to ask you, uh,

114
00:06:24,760 --> 00:06:27,720
before we close is what are
you excited about today?

115
00:06:27,860 --> 00:06:29,360
And also what is making you nervous?

116
00:06:31,270 --> 00:06:32,030
So, you know,

117
00:06:32,030 --> 00:06:36,370
I'm excited about and also nervous
about some of the new weight loss and

118
00:06:36,610 --> 00:06:40,610
diabetic drugs that are recently
becoming very popular. Um, you know,

119
00:06:40,930 --> 00:06:44,410
everyone's heard of them, they're all
over the news. Ozempic, wego, Manjaro,

120
00:06:44,410 --> 00:06:49,010
there are others. Um, I think it's a
phenomenal pharmaceutical innovation. Um,

121
00:06:49,210 --> 00:06:53,330
I think there's a lot of patient interest
and, um, use now, uh, getting, um,

122
00:06:53,920 --> 00:06:54,970
more and more rampant.

123
00:06:55,160 --> 00:06:57,930
It's really helping people lose weight
and it's really helping our diabetic

124
00:06:57,930 --> 00:07:01,170
patients get those blood sugars down
and treat their diabetes effectively.

125
00:07:01,470 --> 00:07:04,370
So it's really exciting and I think
they're gonna be potentially big game

126
00:07:04,370 --> 00:07:09,290
changers in, um, making sure we keep
people at, at the right B m I and, um,

127
00:07:09,290 --> 00:07:11,450
really help them manage,
uh, a chronic disease,

128
00:07:11,450 --> 00:07:13,530
which is very important to
manage, which is diabetes.

129
00:07:14,310 --> 00:07:17,010
So on one hand it's
just super exciting, um,

130
00:07:17,010 --> 00:07:20,050
and the early results in terms
of how effective they are, uh,

131
00:07:20,050 --> 00:07:22,530
they're very good at controlling
diabetes and they've promoted significant

132
00:07:22,530 --> 00:07:26,650
weight loss relatively rapidly. I
think this is really exciting, um,

133
00:07:26,660 --> 00:07:29,490
early findings and,
um, generally speaking,

134
00:07:29,490 --> 00:07:33,130
patients are interested in them and are
are, you know, willing to go on them.

135
00:07:34,270 --> 00:07:36,330
So that's all good. And uh, you know,

136
00:07:36,330 --> 00:07:38,410
if they continue to be
as effective as they are,

137
00:07:38,530 --> 00:07:41,890
I think we'll see significant
improvements in metabolic syndrome, um,

138
00:07:41,890 --> 00:07:45,170
and a lot of the risk factors
that drive cardiovascular disease.

139
00:07:45,430 --> 00:07:46,730
So as a cardiologist, you know,

140
00:07:46,850 --> 00:07:49,770
anything could do on the front end to
prevent disease on the back end, you know,

141
00:07:49,790 --> 00:07:52,850
you know, that means we're treating
people better and earlier. So that's,

142
00:07:52,850 --> 00:07:54,890
that's the really exciting part. Um,

143
00:07:54,930 --> 00:07:58,010
I guess it would make me a little nervous
because we're using them pretty widely

144
00:07:58,190 --> 00:08:01,690
now and we don't know yet, like with
any new medication or treatment,

145
00:08:01,720 --> 00:08:05,450
what the potential side effects
will be. Um, but I think, you know,

146
00:08:05,470 --> 00:08:08,730
we will learn, I think they're being
monitored pretty carefully and um,

147
00:08:09,010 --> 00:08:11,970
hopefully there won't be any
significant side effects that, uh,

148
00:08:11,970 --> 00:08:14,610
really prevent our ability
to continue to, you know,

149
00:08:14,610 --> 00:08:18,370
utilize these medications appropriately.
So again, I think it's a great area.

150
00:08:18,530 --> 00:08:22,370
I think it's a very interesting
and evolving area. It
makes me very excited and,

151
00:08:22,370 --> 00:08:26,090
uh, and also always a little bit, um,
cautious. I guess that's what I would say.

152
00:08:28,150 --> 00:08:31,380
Absolutely. And thank you so much
for those final thoughts, doctor.

153
00:08:31,810 --> 00:08:33,260
This has been an amazing discussion.

154
00:08:33,320 --> 00:08:36,740
So I wanna thank you again for coming on
Becker's Healthcare and I look forward

155
00:08:36,740 --> 00:08:37,940
to connecting with you again soon.

156
00:08:38,750 --> 00:08:40,540
Thank you so much and
a pleasure to meet you.

